Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy-updated results from an expanded access programme

被引：0

作者：

Petruzelka, L. ^{[1
]}

Zimovjanova, M. ^{[1
]}

Konopasek, B. ^{[1
]}

Mares, P. ^{[1
]}

Dlouha, Z. ^{[1
]}

机构：

[1] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：36 / 36

页数：1

共 50 条

[1] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - updated results from an expanded access programme
不详
EJC SUPPLEMENTS, 2006, 4 (02): : 171 - 171
[2] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from an expanded access programme
Petruzelka, L.
Zimovjanova, M.
EJC SUPPLEMENTS, 2004, 2 (03): : 132 - 133
[3] Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - results from a compassionate use program.
Petruzelka, L
Zimovjanova, M
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 59S - 59S
[4] Fulvestrant in postmenopausal women with locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy: a guide
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2015, 31 (10) : 323 - 328
[5] Evidence of continued sensitivity to endocrine agents in postmenopausal women with advanced breast cancer progressing on fulvestrant ('Faslodex®')
Vergote, I
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 288 - 288
[6] Endocrine response after prior treatment with fulvestrant (Fasiodex®) in postmenopausal women with advanced breast cancer
Cheung, K
Robertson, JFR
Scott, N
Owers, R
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S99
[7] Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
Howell, A
Robertson, JFR
Albano, JQ
Aschermannova, A
Mauriac, L
Kleeberg, UR
Vergote, I
Erikstein, B
Webster, A
Morris, C
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3396 - 3403
[8] Double-blind, Randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: Results of a North American trial
Osborne, CK
Pippen, J
Jones, SE
Parker, LM
Ellis, M
Come, S
Gertler, SZ
May, JT
Burton, G
Dimery, I
Webster, A
Morris, C
Elledge, R
Buzdar, A
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3386 - 3395
[9] Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
I Vergote
J F R Robertson
British Journal of Cancer, 2004, 90 : S11 - S14
[10] Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
Vergote, I
Robertson, JFR
BRITISH JOURNAL OF CANCER, 2004, 90 (Suppl 1) : S11 - S14

← 1 2 3 4 5 →